Wockhardt Buys Out Rhein Biotech From Joint Venture
Pharmaceutical major Wockhardt has bought out Rhein Biotech GmbH from their 50:50 joint venture, Wockhardt Rhein Biopharm, for an undisclosed sum.
Wockhardt will continue to hold a co-exclusive licence on Rhein